Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA.
UNDER a Biden-Harris Administration, expect to experience a sustained ‘Green Rush’ delivering a multi-trillion dollar boost to the United Sates cannabis economy.
The duo support recreational-use decriminalisation of cannabis, removing cannabis as a Schedule I drug in the Controlled Substances Act, and Federal medical legalisation; deferring to each State to manage and set laws pertaining to the cannabis economy.
Under the new administration, we anticipate the passage of either or both of the STATES and MORE Acts – which will allow for access to capital markets and financial services without risk of Federal sanctions.
This should allow cannabis business start-ups and existing operators to trade, as in any other commercialised industry.
Cannabis: The US Economic Saviour?
Prior to the Covid-19 pandemic, the US was already witnessing voter majority support trending towards legalising recreational-use in the states where medicinal-use is permitted.
The resulting increase in recreational sales during the pandemic – determined an essential service during state-wide lockdowns – has boosted analysts growth trajectories to $16bn in sales this year, up by $4bn from last year.
With the severely depressed state of the US economy resulting from the Trump Administration’s failure to appropriately manage the Covid-19 crisis, the complete elimination of businesses across multiple traditional industry domains and soaring unemployment rates, cannabis looks to be set the US’ saviour.
It has the potential to create new jobs and significantly boost Federal and State tax revenues.
Support for cannabis to resurrect the country’s economy was evidenced through ballots which saw an additional five states legalise cannabis.
These included; New Jersey, Arizona, Montana, Mississippi and South Dakota, bringing Cannabis legalisation to 36 of the 50 US States for medical-use and 15 states for recreational-use.
Looking at the potential revenues generated through legal cannabis businesses demonstrate the overwhelming economic argument, for the remaining States to join the club.
The State of Colorado legalised cannabis in 2012 and, as of September 2020, reported over $1.2bn annual sales, delivering State tax revenues of approximately $225m.
Oregon legalised medical-use in 1998 and became one of the first States to legalise recreational-use in 2014. It now has monthly sales of around $100m.
In Q2, 2020, California reported $85m in sales tax revenue and $22m in cultivation taxes and Illinois, only recently minted as a legal cannabis state, is now witnessing record sales in the realm of $70m a month.
Legalisation in New Jersey is expected to generate approximately $1bn a year and other States will be enviously wanting join these ranks.
Investments Across Every Sub-Sector
Under this new Administration, US entrepreneurs and companies will be increasingly confident to start and operate cannabis businesses.
Therefore, expect to see an up-tick in start-ups in every sub-sector, with investments pouring in to an industry which has proven to be stable during an otherwise fiscally-fraught time.
As the cannabis economy matures and displays increasing sophistication, we expect to see acquisitions from the leading CPG companies who have not been unable to touch the space due to the lack of Federal regulations.
And, thereafter there will be moves towards a global expansion, through traditional avenues, making cannabis the hottest commodity since sliced bread!
Under the Biden-Harris Presidency The Cannabis Industry Can Deliver A Significant Boost To The Whole US Economy
Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA.
UNDER a Biden-Harris Administration, expect to experience a sustained ‘Green Rush’ delivering a multi-trillion dollar boost to the United Sates cannabis economy.
The duo support recreational-use decriminalisation of cannabis, removing cannabis as a Schedule I drug in the Controlled Substances Act, and Federal medical legalisation; deferring to each State to manage and set laws pertaining to the cannabis economy.
Under the new administration, we anticipate the passage of either or both of the STATES and MORE Acts – which will allow for access to capital markets and financial services without risk of Federal sanctions.
This should allow cannabis business start-ups and existing operators to trade, as in any other commercialised industry.
Cannabis: The US Economic Saviour?
Prior to the Covid-19 pandemic, the US was already witnessing voter majority support trending towards legalising recreational-use in the states where medicinal-use is permitted.
The resulting increase in recreational sales during the pandemic – determined an essential service during state-wide lockdowns – has boosted analysts growth trajectories to $16bn in sales this year, up by $4bn from last year.
With the severely depressed state of the US economy resulting from the Trump Administration’s failure to appropriately manage the Covid-19 crisis, the complete elimination of businesses across multiple traditional industry domains and soaring unemployment rates, cannabis looks to be set the US’ saviour.
It has the potential to create new jobs and significantly boost Federal and State tax revenues.
Support for cannabis to resurrect the country’s economy was evidenced through ballots which saw an additional five states legalise cannabis.
These included; New Jersey, Arizona, Montana, Mississippi and South Dakota, bringing Cannabis legalisation to 36 of the 50 US States for medical-use and 15 states for recreational-use.
Looking at the potential revenues generated through legal cannabis businesses demonstrate the overwhelming economic argument, for the remaining States to join the club.
The State of Colorado legalised cannabis in 2012 and, as of September 2020, reported over $1.2bn annual sales, delivering State tax revenues of approximately $225m.
Oregon legalised medical-use in 1998 and became one of the first States to legalise recreational-use in 2014. It now has monthly sales of around $100m.
In Q2, 2020, California reported $85m in sales tax revenue and $22m in cultivation taxes and Illinois, only recently minted as a legal cannabis state, is now witnessing record sales in the realm of $70m a month.
Legalisation in New Jersey is expected to generate approximately $1bn a year and other States will be enviously wanting join these ranks.
Investments Across Every Sub-Sector
Under this new Administration, US entrepreneurs and companies will be increasingly confident to start and operate cannabis businesses.
Therefore, expect to see an up-tick in start-ups in every sub-sector, with investments pouring in to an industry which has proven to be stable during an otherwise fiscally-fraught time.
As the cannabis economy matures and displays increasing sophistication, we expect to see acquisitions from the leading CPG companies who have not been unable to touch the space due to the lack of Federal regulations.
And, thereafter there will be moves towards a global expansion, through traditional avenues, making cannabis the hottest commodity since sliced bread!
Elle Rahman, CEO, OME Health
Is cannabis now a bipartisan issue in the United States?
Next PostUnderstanding the medical cannabis patient perspective in Canada
Peter
Related Posts
Related Posts
It Is High Time for a Renaissance in the UK Cannabis Industry
Written for Business of Cannabis by Andrew Pepper, Partner at business restructuring and consultancy firm ReSolve Advisory. In January...
Chill Brands CEO Suspended Amid Allegations Of ‘Use of Inside Information’, SynBiotic Buys Croatian CBD Maker, & Hellenic Secures Funding
Chill Brands Chill Brands has seen its share price dive by nearly 40% this week after news emerged that...
Tikun Olam Europe Leads the Change in Greece’s Rapidly Evolving Medical Cannabis Landscape
Cannabis Associations in Germany Face New Restrictions in Push to Prevent Commercialisation
#ReleaseOurMeds Campaign Launches to Protect the Rights of Patients to Access Their Medicine
Jersey Hemp Wins Watershed Legal Battle Against UK Home Office Which Threatened Entire CBD Industry
CONNECT
Related Posts
Related Posts
It Is High Time for a Renaissance in the UK Cannabis Industry
Written for Business of Cannabis by Andrew Pepper, Partner at business restructuring and consultancy firm ReSolve Advisory. In January...
Chill Brands CEO Suspended Amid Allegations Of ‘Use of Inside Information’, SynBiotic Buys Croatian CBD Maker, & Hellenic Secures Funding
Chill Brands Chill Brands has seen its share price dive by nearly 40% this week after news emerged that...
Tikun Olam Europe Leads the Change in Greece’s Rapidly Evolving Medical Cannabis Landscape
Earlier this year, Greece became the latest EU country to make medical cannabis products available to patients. In February 2024,...
Cannabis Associations in Germany Face New Restrictions in Push to Prevent Commercialisation
The German government is reportedly set to push through legislation that would tighten the already strict rules around cultivation associations....
#ReleaseOurMeds Campaign Launches to Protect the Rights of Patients to Access Their Medicine
Release is launching a vital initiative. We are launching the #ReleaseOurMeds campaign to protect the rights of patients to access...
Recent Posts
Related Posts
Cannabis Reform Takes Center Stage in Presidential Address, But Reactions Mixed
President Joe Biden used his State of the Union address to reaffirm his commitment to cannabis reform, marking the first...
Flora Growth Announces Sale of Colombian Assets
Florida-based Flora Growth has announced the sale of its Colombian-related subsidiaries and assets to a private company for CAD$0.8 million....
Cannabis Data for Rescheduling Review Handed to Government
A number of states have handed over cannabis data to the US Government in view of the upcoming cannabis rescheduling...
CBD industry currently thriving in Europe, says report
The European CBD Report: Health & Wellness has been published by Prohibition Partners and sponsored by Atalis.Â
Virginia House panel kills GOP-led push to legalize retail cannabis sales
VIRGINIA CANNABIS Virginia House panel kills GOP-led push to legalize retail cannabis sales Benzinga reports that Virginia lawmakers struck down...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags